Innovative Product Regulatory Strategies and Considerations for Medical Devices and IVDs
As the global medical practice undergoes drastic change embracing faster access to innovative technologies, getting the regulatory strategy right from the onset can mean the difference between success and failure. In this webinar, we discuss the key considerations for registering innovative products and changes to existing products incorporating innovative modifications. We will focus on the current regulatory issues and requirements when evaluating alternative pathways for TGA, EU, and the US including rare-disease designations, priority review, and provisional approvals. Special note will be taken on how the MDR and IVDR transitions are impacting innovative product registrations and product changes. Key trends such as the use of Real World Evidence, MDSAP, and risk-based biocompatibility management will be discussed
Видео Innovative Product Regulatory Strategies and Considerations for Medical Devices and IVDs канала Brandwood CKC
Видео Innovative Product Regulatory Strategies and Considerations for Medical Devices and IVDs канала Brandwood CKC
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Traps for the unwary on quality systems – design controls before you manufactureBiocompatibility Challenges for 2019Market Access in Australia – leveraging international approvals for TGA registrationsDo I really need that clinical trial? A global approach to clinical evidenceHitting the Accelerator October 2020 WebinarTime to get serious on postmarketBuilding a Technical File - Brandwood Biomedical WebinarMedical Device Regulations Under COVID-19. What you need to know.The Case For QualityHarmonisation - Triumphs and TragediesClinical Evaluation Report Webinar June 2020Webinar (Feb 2017) Postmarket Compliance ISO 134852016 & New European Medical Device RegulationsMedical Device Software: Current Developments in the Regulatory WorldMedical Device Sponsorship Requirements for Australia and New ZealandBIOCOMPATIBILITY Webinar March 2020Top FAQs for 2020Blood, Sweat and Tears - An Update to In Vitro Diagnostics Regulatory Requirements World WideFDA and ISO stars aligning on ISO 10993Documentation Deconstructed: Understanding the Technical fileClinical Trials Down Under - Skipping regulatory approvals!Why MDSAP opens a world of opportunity.